A-68930
 | |
| Names | |
|---|---|
| IUPAC name
(1R,3S)-1-(Aminomethyl)-3-phenyl-3,4-dihydro-1H-isochromene-5,6-diol[1] | |
| Identifiers | |
130465-45-1  130465-39-3 (HCl)  | |
| 3D model (Jmol) | Interactive image |
| ChEMBL | ChEMBL315468 |
| ChemSpider | 109076 |
| 6077 | |
| MeSH | A+68930 |
| PubChem | 122324 |
| |
| |
| Properties | |
| C16H17NO3 | |
| Molar mass | 271.32 g·mol−1 |
| log P | 1.175 |
| Acidity (pKa) | 9.491 |
| Basicity (pKb) | 4.506 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| verify (what is ?) | |
| Infobox references | |
A-68930 is a synthetic compound that acts as a selective dopamine receptor D1 partial agonist.[2][3] It is orally active and has antidepressant and anorectic effects in animals, producing wakefulness and tachycardia,[4][5][6][7] but without stimulant effects, instead producing sedation.[8][9] The difference in effects between A-68930 and other D1 agonists such as SKF-82958 may be due to their differing effects on the related D5 receptor.[10]
References
- ↑ CID 122324 from PubChem
- ↑ DeNinno MP, Schoenleber R, Asin KE, MacKenzie R, Kebabian JW (November 1990). "(1R,3S)-1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran: a potent and selective D1 agonist". Journal of Medicinal Chemistry. 33 (11): 2948–50. doi:10.1021/jm00173a005. PMID 1977907.
- ↑ DeNinno MP, Schoenleber R, MacKenzie R, Britton DR, Asin KE, Briggs C, Trugman JM, Ackerman M, Artman L, Bednarz L (June 1991). "A68930: a potent agonist selective for the dopamine D1 receptor". European Journal of Pharmacology. 199 (2): 209–19. doi:10.1016/0014-2999(91)90459-4. PMID 1683288.
- ↑ Trampus M, Ferri N, Adami M, Ongini E (April 1993). "The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat". European Journal of Pharmacology. 235 (1): 83–7. doi:10.1016/0014-2999(93)90823-Z. PMID 8100197.
- ↑ Christie MI, Smith GW (February 1994). "Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam". The Journal of Pharmacology and Experimental Therapeutics. 268 (2): 565–70. PMID 7906731.
- ↑ AI-Naser HA, Cooper SJ (April 1994). "A-68930, a novel, potent dopamine D1 receptor agonist: a microstructural analysis of its effects on feeding and other behaviour in the rat". Behavioural Pharmacology. 5 (2): 210–218. doi:10.1097/00008877-199404000-00013. PMID 11224270.
- ↑ D'Aquila PS, Collu M, Pani L, Gessa GL, Serra G (September 1994). "Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression". European Journal of Pharmacology. 262 (1–2): 107–11. doi:10.1016/0014-2999(94)90033-7. PMID 7813561.
- ↑ Salmi P, Ahlenius S (April 2000). "Sedative effects of the dopamine D1 receptor agonist A 68930 on rat open-field behavior". NeuroReport. 11 (6): 1269–72. doi:10.1097/00001756-200004270-00025. PMID 10817605.
- ↑ Isacson R, Kull B, Wahlestedt C, Salmi P (2004). "A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?". Neuroscience. 124 (1): 33–42. doi:10.1016/j.neuroscience.2003.11.016. PMID 14960337.
- ↑ Nergårdh R, Oerther S, Fredholm BB (November 2005). "Differences between A 68930 and SKF 82958 could suggest synergistic roles of D1 and D5 receptors". Pharmacology, Biochemistry, and Behavior. 82 (3): 495–505. doi:10.1016/j.pbb.2005.09.017. PMID 16318870.
This article is issued from Wikipedia - version of the 5/18/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.